ID   FIG4_HUMAN              Reviewed;         907 AA.
AC   Q92562; Q53H49; Q5TCS6;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   15-MAR-2017, entry version 139.
DE   RecName: Full=Polyphosphoinositide phosphatase;
DE            EC=3.1.3.-;
DE   AltName: Full=Phosphatidylinositol 3,5-bisphosphate 5-phosphatase;
DE   AltName: Full=SAC domain-containing protein 3;
GN   Name=FIG4; Synonyms=KIAA0274, SAC3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=9039502; DOI=10.1093/dnares/3.5.321;
RA   Nagase T., Seki N., Ishikawa K., Ohira M., Kawarabayasi Y., Ohara O.,
RA   Tanaka A., Kotani H., Miyajima N., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. VI.
RT   The coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by
RT   analysis of cDNA clones from cell line KG-1 and brain.";
RL   DNA Res. 3:321-329(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-654.
RC   TISSUE=Colon;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, IDENTIFICATION IN THE PI(3,5)P2
RP   REGULATORY COMPLEX, AND MUTAGENESIS OF ASP-488.
RX   PubMed=17556371; DOI=10.1074/jbc.M611678200;
RA   Sbrissa D., Ikonomov O.C., Fu Z., Ijuin T., Gruenberg J., Takenawa T.,
RA   Shisheva A.;
RT   "Core protein machinery for mammalian phosphatidylinositol 3,5-
RT   bisphosphate synthesis and turnover that regulates the progression of
RT   endosomal transport. Novel Sac phosphatase joins the ArPIKfyve-PIKfyve
RT   complex.";
RL   J. Biol. Chem. 282:23878-23891(2007).
RN   [6]
RP   IDENTIFICATION IN THE PI(3,5)P2 REGULATORY COMPLEX.
RX   PubMed=18950639; DOI=10.1016/j.jmb.2008.10.009;
RA   Sbrissa D., Ikonomov O.C., Fenner H., Shisheva A.;
RT   "ArPIKfyve homomeric and heteromeric interactions scaffold PIKfyve and
RT   Sac3 in a complex to promote PIKfyve activity and functionality.";
RL   J. Mol. Biol. 384:766-779(2008).
RN   [7]
RP   VARIANT CMT4J THR-41.
RX   PubMed=17572665; DOI=10.1038/nature05876;
RA   Chow C.Y., Zhang Y., Dowling J.J., Jin N., Adamska M., Shiga K.,
RA   Szigeti K., Shy M.E., Li J., Zhang X., Lupski J.R., Weisman L.S.,
RA   Meisler M.H.;
RT   "Mutation of FIG4 causes neurodegeneration in the pale tremor mouse
RT   and patients with CMT4J.";
RL   Nature 448:68-72(2007).
RN   [8]
RP   VARIANT ALS11 TYR-53, AND VARIANTS GLY-48; GLY-388; VAL-411; CYS-647
RP   AND THR-902.
RX   PubMed=19118816; DOI=10.1016/j.ajhg.2008.12.010;
RA   Chow C.Y., Landers J.E., Bergren S.K., Sapp P.C., Grant A.E.,
RA   Jones J.M., Everett L., Lenk G.M., McKenna-Yasek D.M., Weisman L.S.,
RA   Figlewicz D., Brown R.H., Meisler M.H.;
RT   "Deleterious variants of FIG4, a phosphoinositide phosphatase, in
RT   patients with ALS.";
RL   Am. J. Hum. Genet. 84:85-88(2009).
RN   [9]
RP   VARIANTS CMT4J PRO-17; THR-41 AND LYS-302, AND CHARACTERIZATION OF
RP   VARIANT CMT4J LYS-302.
RX   PubMed=21705420; DOI=10.1093/brain/awr148;
RA   Nicholson G., Lenk G.M., Reddel S.W., Grant A.E., Towne C.F.,
RA   Ferguson C.J., Simpson E., Scheuerle A., Yasick M., Hoffman S.,
RA   Blouin R., Brandt C., Coppola G., Biesecker L.G., Batish S.D.,
RA   Meisler M.H.;
RT   "Distinctive genetic and clinical features of CMT4J: a severe
RT   neuropathy caused by mutations in the PI(3,5)P(2) phosphatase FIG4.";
RL   Brain 134:1959-1971(2011).
RN   [10]
RP   CHARACTERIZATION OF VARIANT CMT4J THR-41.
RX   PubMed=21655088; DOI=10.1371/journal.pgen.1002104;
RA   Lenk G.M., Ferguson C.J., Chow C.Y., Jin N., Jones J.M., Grant A.E.,
RA   Zolov S.N., Winters J.J., Giger R.J., Dowling J.J., Weisman L.S.,
RA   Meisler M.H.;
RT   "Pathogenic mechanism of the FIG4 mutation responsible for Charcot-
RT   Marie-Tooth disease CMT4J.";
RL   PLoS Genet. 7:E1002104-E1002104(2011).
RN   [11]
RP   VARIANTS YVS ASP-104 AND PRO-175, AND CHARACTERIZATION OF VARIANTS YVS
RP   ASP-104 AND PRO-175.
RX   PubMed=23623387; DOI=10.1016/j.ajhg.2013.03.020;
RA   Campeau P.M., Lenk G.M., Lu J.T., Bae Y., Burrage L., Turnpenny P.,
RA   Roman Corona-Rivera J., Morandi L., Mora M., Reutter H.,
RA   Vulto-van Silfhout A.T., Faivre L., Haan E., Gibbs R.A., Meisler M.H.,
RA   Lee B.H.;
RT   "Yunis-Varon syndrome is caused by mutations in FIG4, encoding a
RT   phosphoinositide phosphatase.";
RL   Am. J. Hum. Genet. 92:781-791(2013).
RN   [12]
RP   INVOLVEMENT IN BTOP, VARIANT BTOP VAL-783, AND CHARACTERIZATION OF
RP   VARIANT BTOP VAL-783.
RX   PubMed=24598713; DOI=10.1212/WNL.0000000000000241;
RA   Baulac S., Lenk G.M., Dufresnois B., Ouled Amar Bencheikh B.,
RA   Couarch P., Renard J., Larson P.A., Ferguson C.J., Noe E., Poirier K.,
RA   Hubans C., Ferreira S., Guerrini R., Ouazzani R., El Hachimi K.H.,
RA   Meisler M.H., Leguern E.;
RT   "Role of the phosphoinositide phosphatase FIG4 gene in familial
RT   epilepsy with polymicrogyria.";
RL   Neurology 82:1068-1075(2014).
CC   -!- FUNCTION: The PI(3,5)P2 regulatory complex regulates both the
CC       synthesis and turnover of phosphatidylinositol 3,5-bisphosphate
CC       (PtdIns(3,5)P2). In vitro, hydrolyzes all three D5-phosphorylated
CC       polyphosphoinositide substrates in the order PtdIns(4,5)P2 >
CC       PtdIns(3,5)P2 > PtdIns(3,4,5)P3. Plays a role in the biogenesis of
CC       endosome carrier vesicles (ECV) / multivesicular bodies (MVB)
CC       transport intermediates from early endosomes.
CC       {ECO:0000269|PubMed:17556371}.
CC   -!- SUBUNIT: Component of the PI(3,5)P2 regulatory complex/PAS
CC       complex, at least composed of PIKFYVE, FIG4 and VAC14. VAC14
CC       nucleates the assembly of the complex and serves as a scaffold.
CC       {ECO:0000269|PubMed:17556371, ECO:0000269|PubMed:18950639}.
CC   -!- INTERACTION:
CC       Q08AM6:VAC14; NbExp=3; IntAct=EBI-4290773, EBI-2107455;
CC   -!- SUBCELLULAR LOCATION: Endosome membrane
CC       {ECO:0000269|PubMed:17556371}. Note=Localization requires VAC14
CC       and PIKFYVE.
CC   -!- DISEASE: Charcot-Marie-Tooth disease 4J (CMT4J) [MIM:611228]: A
CC       recessive demyelinating form of Charcot-Marie-Tooth disease, a
CC       disorder of the peripheral nervous system, characterized by
CC       progressive weakness and atrophy, initially of the peroneal
CC       muscles and later of the distal muscles of the arms. Charcot-
CC       Marie-Tooth disease is classified in two main groups on the basis
CC       of electrophysiologic properties and histopathology: primary
CC       peripheral demyelinating neuropathies (designated CMT1 when they
CC       are dominantly inherited) and primary peripheral axonal
CC       neuropathies (CMT2). Demyelinating neuropathies are characterized
CC       by severely reduced nerve conduction velocities (less than 38
CC       m/sec), segmental demyelination and remyelination with onion bulb
CC       formations on nerve biopsy, slowly progressive distal muscle
CC       atrophy and weakness, absent deep tendon reflexes, and hollow
CC       feet. By convention autosomal recessive forms of demyelinating
CC       Charcot-Marie-Tooth disease are designated CMT4.
CC       {ECO:0000269|PubMed:17572665, ECO:0000269|PubMed:21655088,
CC       ECO:0000269|PubMed:21705420}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Amyotrophic lateral sclerosis 11 (ALS11) [MIM:612577]: A
CC       neurodegenerative disorder affecting upper motor neurons in the
CC       brain and lower motor neurons in the brain stem and spinal cord,
CC       resulting in fatal paralysis. Sensory abnormalities are absent.
CC       The pathologic hallmarks of the disease include pallor of the
CC       corticospinal tract due to loss of motor neurons, presence of
CC       ubiquitin-positive inclusions within surviving motor neurons, and
CC       deposition of pathologic aggregates. The etiology of amyotrophic
CC       lateral sclerosis is likely to be multifactorial, involving both
CC       genetic and environmental factors. The disease is inherited in 5-
CC       10% of the cases. {ECO:0000269|PubMed:19118816}. Note=The disease
CC       is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Yunis-Varon syndrome (YVS) [MIM:216340]: A severe
CC       autosomal recessive disorder characterized by skeletal defects,
CC       including cleidocranial dysplasia and digital anomalies, and
CC       severe neurologic involvement with neuronal loss. Enlarged
CC       cytoplasmic vacuoles are found in neurons, muscle, and cartilage.
CC       The disorder is usually lethal in infancy.
CC       {ECO:0000269|PubMed:23623387}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Polymicrogyria, bilateral temporooccipital (BTOP)
CC       [MIM:612691]: A disease characterized by temporo-occipital
CC       polymicrogyria, psychiatric manifestations, and epilepsy.
CC       {ECO:0000269|PubMed:24598713}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA13403.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D87464; BAA13403.2; ALT_INIT; mRNA.
DR   EMBL; AK222732; BAD96452.1; -; mRNA.
DR   EMBL; AL133472; CAI19669.1; -; Genomic_DNA.
DR   EMBL; AL512303; CAI19669.1; JOINED; Genomic_DNA.
DR   EMBL; AL512303; CAI42494.1; -; Genomic_DNA.
DR   EMBL; AL133472; CAI42494.1; JOINED; Genomic_DNA.
DR   EMBL; BC041338; AAH41338.1; -; mRNA.
DR   CCDS; CCDS5078.1; -.
DR   RefSeq; NP_055660.1; NM_014845.5.
DR   UniGene; Hs.529959; -.
DR   ProteinModelPortal; Q92562; -.
DR   BioGrid; 115225; 7.
DR   IntAct; Q92562; 1.
DR   MINT; MINT-2812974; -.
DR   STRING; 9606.ENSP00000230124; -.
DR   DEPOD; Q92562; -.
DR   iPTMnet; Q92562; -.
DR   PhosphoSitePlus; Q92562; -.
DR   SwissPalm; Q92562; -.
DR   BioMuta; FIG4; -.
DR   DMDM; 2497367; -.
DR   EPD; Q92562; -.
DR   MaxQB; Q92562; -.
DR   PaxDb; Q92562; -.
DR   PeptideAtlas; Q92562; -.
DR   PRIDE; Q92562; -.
DR   TopDownProteomics; Q92562; -.
DR   Ensembl; ENST00000230124; ENSP00000230124; ENSG00000112367.
DR   GeneID; 9896; -.
DR   KEGG; hsa:9896; -.
DR   UCSC; uc003ptt.3; human.
DR   CTD; 9896; -.
DR   DisGeNET; 9896; -.
DR   GeneCards; FIG4; -.
DR   GeneReviews; FIG4; -.
DR   HGNC; HGNC:16873; FIG4.
DR   HPA; CAB017823; -.
DR   HPA; HPA068859; -.
DR   MalaCards; FIG4; -.
DR   MIM; 216340; phenotype.
DR   MIM; 609390; gene.
DR   MIM; 611228; phenotype.
DR   MIM; 612577; phenotype.
DR   MIM; 612691; phenotype.
DR   neXtProt; NX_Q92562; -.
DR   OpenTargets; ENSG00000112367; -.
DR   Orphanet; 803; Amyotrophic lateral sclerosis.
DR   Orphanet; 208441; Bilateral parasagittal parieto-occipital polymicrogyria.
DR   Orphanet; 139515; Charcot-Marie-Tooth disease type 4J.
DR   Orphanet; 35689; Primary lateral sclerosis.
DR   Orphanet; 3472; Yunis-Varon syndrome.
DR   PharmGKB; PA162388528; -.
DR   eggNOG; KOG1888; Eukaryota.
DR   eggNOG; COG5329; LUCA.
DR   GeneTree; ENSGT00550000074943; -.
DR   HOGENOM; HOG000168063; -.
DR   InParanoid; Q92562; -.
DR   OMA; HKQDKNS; -.
DR   OrthoDB; EOG091G01F4; -.
DR   PhylomeDB; Q92562; -.
DR   TreeFam; TF105702; -.
DR   BioCyc; MetaCyc:HS12771-MONOMER; -.
DR   Reactome; R-HSA-1660514; Synthesis of PIPs at the Golgi membrane.
DR   Reactome; R-HSA-1660516; Synthesis of PIPs at the early endosome membrane.
DR   Reactome; R-HSA-1660517; Synthesis of PIPs at the late endosome membrane.
DR   GeneWiki; Fig4; -.
DR   GenomeRNAi; 9896; -.
DR   PRO; PR:Q92562; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000112367; -.
DR   CleanEx; HS_FIG4; -.
DR   ExpressionAtlas; Q92562; baseline and differential.
DR   Genevisible; Q92562; HS.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0010008; C:endosome membrane; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0031902; C:late endosome membrane; TAS:Reactome.
DR   GO; GO:0005811; C:lipid particle; IDA:HPA.
DR   GO; GO:0055037; C:recycling endosome; IEA:Ensembl.
DR   GO; GO:0043813; F:phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity; TAS:Reactome.
DR   GO; GO:0004438; F:phosphatidylinositol-3-phosphatase activity; IEA:Ensembl.
DR   GO; GO:0043812; F:phosphatidylinositol-4-phosphate phosphatase activity; IEA:Ensembl.
DR   GO; GO:0007626; P:locomotory behavior; IEA:Ensembl.
DR   GO; GO:0032288; P:myelin assembly; IEA:Ensembl.
DR   GO; GO:0031642; P:negative regulation of myelination; IEA:Ensembl.
DR   GO; GO:0048666; P:neuron development; IEA:Ensembl.
DR   GO; GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome.
DR   GO; GO:0043473; P:pigmentation; IEA:Ensembl.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl.
DR   GO; GO:0007033; P:vacuole organization; IEA:Ensembl.
DR   InterPro; IPR002013; SAC_dom.
DR   Pfam; PF02383; Syja_N; 1.
DR   PROSITE; PS50275; SAC; 1.
PE   1: Evidence at protein level;
KW   Amyotrophic lateral sclerosis; Charcot-Marie-Tooth disease;
KW   Complete proteome; Disease mutation; Endosome; Hydrolase; Membrane;
KW   Neurodegeneration; Neuropathy; Polymorphism; Reference proteome.
FT   CHAIN         1    907       Polyphosphoinositide phosphatase.
FT                                /FTId=PRO_0000209743.
FT   DOMAIN      154    547       SAC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00183}.
FT   COMPBIAS    746    749       Poly-Pro.
FT   COMPBIAS    755    758       Poly-Ser.
FT   VARIANT      17     17       L -> P (in CMT4J; dbSNP:rs587777713).
FT                                {ECO:0000269|PubMed:21705420}.
FT                                /FTId=VAR_071957.
FT   VARIANT      41     41       I -> T (in CMT4J; the mutant protein is
FT                                unstable; low levels of the protein
FT                                results from impaired interaction with
FT                                VAC14; dbSNP:rs121908287).
FT                                {ECO:0000269|PubMed:17572665,
FT                                ECO:0000269|PubMed:21655088,
FT                                ECO:0000269|PubMed:21705420}.
FT                                /FTId=VAR_036974.
FT   VARIANT      48     48       D -> G. {ECO:0000269|PubMed:19118816}.
FT                                /FTId=VAR_054831.
FT   VARIANT      53     53       D -> Y (in ALS11; dbSNP:rs121908290).
FT                                {ECO:0000269|PubMed:19118816}.
FT                                /FTId=VAR_054832.
FT   VARIANT     104    104       G -> D (in YVS; complete loss of function
FT                                mutation; dbSNP:rs397509395).
FT                                {ECO:0000269|PubMed:23623387}.
FT                                /FTId=VAR_070051.
FT   VARIANT     175    175       L -> P (in YVS; complete loss of function
FT                                mutation; dbSNP:rs397514707).
FT                                {ECO:0000269|PubMed:23623387}.
FT                                /FTId=VAR_070052.
FT   VARIANT     302    302       E -> K (in CMT4J; loss of function;
FT                                dbSNP:rs587777714).
FT                                {ECO:0000269|PubMed:21705420}.
FT                                /FTId=VAR_071958.
FT   VARIANT     364    364       M -> L (in dbSNP:rs2295837).
FT                                /FTId=VAR_020378.
FT   VARIANT     388    388       R -> G. {ECO:0000269|PubMed:19118816}.
FT                                /FTId=VAR_054833.
FT   VARIANT     411    411       I -> V. {ECO:0000269|PubMed:19118816}.
FT                                /FTId=VAR_054834.
FT   VARIANT     647    647       Y -> C (in dbSNP:rs150301327).
FT                                {ECO:0000269|PubMed:19118816}.
FT                                /FTId=VAR_054835.
FT   VARIANT     654    654       V -> A (in dbSNP:rs9885672).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_022826.
FT   VARIANT     783    783       D -> V (in BTOP; partial loss of
FT                                function; dbSNP:rs587777716).
FT                                {ECO:0000269|PubMed:24598713}.
FT                                /FTId=VAR_071959.
FT   VARIANT     902    902       I -> T. {ECO:0000269|PubMed:19118816}.
FT                                /FTId=VAR_054836.
FT   MUTAGEN     488    488       D->A: Loss of activity.
FT                                {ECO:0000269|PubMed:17556371}.
FT   CONFLICT    310    310       V -> A (in Ref. 2; BAD96452).
FT                                {ECO:0000305}.
FT   CONFLICT    453    453       S -> P (in Ref. 2; BAD96452).
FT                                {ECO:0000305}.
FT   CONFLICT    598    598       F -> S (in Ref. 2; BAD96452).
FT                                {ECO:0000305}.
SQ   SEQUENCE   907 AA;  103635 MW;  7B6F115C095EC332 CRC64;
     MPTAAAPIIS SVQKLVLYET RARYFLVGSN NAETKYRVLK IDRTEPKDLV IIDDRHVYTQ
     QEVRELLGRL DLGNRTKMGQ KGSSGLFRAV SAFGVVGFVR FLEGYYIVLI TKRRKMADIG
     GHAIYKVEDT NMIYIPNDSV RVTHPDEARY LRIFQNVDLS SNFYFSYSYD LSHSLQYNLT
     VLRMPLEMLK SEMTQNRQES FDIFEDEGLI TQGGSGVFGI CSEPYMKYVW NGELLDIIKS
     TVHRDWLLYI IHGFCGQSKL LIYGRPVYVT LIARRSSKFA GTRFLKRGAN CEGDVANEVE
     TEQILCDASV MSFTAGSYSS YVQVRGSVPL YWSQDISTMM PKPPITLDQA DPFAHVAALH
     FDQMFQRFGS PIIILNLVKE REKRKHERIL SEELVAAVTY LNQFLPPEHT IVYIPWDMAK
     YTKSKLCNVL DRLNVIAESV VKKTGFFVNR PDSYCSILRP DEKWNELGGC VIPTGRLQTG
     ILRTNCVDCL DRTNTAQFMV GKCALAYQLY SLGLIDKPNL QFDTDAVRLF EELYEDHGDT
     LSLQYGGSQL VHRVKTYRKI APWTQHSKDI MQTLSRYYSN AFSDADRQDS INLFLGVFHP
     TEGKPHLWEL PTDFYLHHKN TMRLLPTRRS YTYWWTPEVI KHLPLPYDEV ICAVNLKKLI
     VKKFHKYEEE IDIHNEFFRP YELSSFDDTF CLAMTSSARD FMPKTVGIDP SPFTVRKPDE
     TGKSVLGNKS NREEAVLQRK TAASAPPPPS EEAVSSSSED DSGTDREEEG SVSQRSTPVK
     MTDAGDSAKV TENVVQPMKE LYGINLSDGL SEEDFSIYSR FVQLGQSQHK QDKNSQQPCS
     RCSDGVIKLT PISAFSQDNI YEVQPPRVDR KSTEIFQAHI QASQGIMQPL GKEDSSMYRE
     YIRNRYL
//
